But why would more severe acute illness be less likely to be a precursor to ME/CFS ? If acute infection has a causal role in ME/CFS, yet neither symptom insignificant nor severe infections have the same propensity to lead to ME/CFS as mild acute illness, then some very specific processes have to be in play and I'm not clear what line of reasoning could begin to elucidate what those processes might be. How can mild illness be more damaging than severe illness ?
Perhaps both ends of the spectrum involve immune dysregulation. The acute end presents as eg ARDS, occurring within days. The ME/CFS end may be a slow burn that takes weeks to overcome various homeostatic mechanisms to tip over to the pathological state (which may ultimately be experienced as an "on-switch" by the patient).
From SARS-CoV-2 pathogenesis (2022)
Soon after the onset of dyspnoea and hypoxaemia, progressive respiratory failure develops in patients with severe COVID-19. These patients generally meet the criteria for ARDS, which is defined as severe hypoxaemia and bilateral radiographic opacities occurring within 7 days of exposure to known predisposing factors that is not fully explained by heart failure or fluid overload. ARDS is a form of lung injury that is characterized by inflammation, pulmonary vascular leakage and consequently a loss of aerated lung tissue. Patients with COVID-19 with hypoxic respiratory failure have evidence of systemic hyperinflammation, including release of pro-inflammatory cytokines, such as interleukin-1 (IL-1), IL-6, IL-8 and TNF, and elevated concentrations of inflammatory markers, including D-dimer, ferritin and C-reactive protein (CRP). Serum levels of IL-6, IL-8 and TNF at the time of hospitalization are strong and independent predictors of patient survival.
From Long COVID: major findings, mechanisms and recommendations (2023)
Studies looking at immune dysregulation in individuals with long COVID who had mild acute COVID-19 have found T cell alterations, including exhausted T cells18, reduced CD4+ and CD8+ effector memory cell numbers and elevated PD1 expression on central memory cells, persisting for at least 13 months. Studies have also reported highly activated innate immune cells, a lack of naive T and B cells and elevated expression of type I and type III interferons (interferon-β (IFNβ) and IFNλ1), persisting for at least 8 months.
But perversely, severe acute disease may give better odds for good long-term outcome: it's recognisable so attempts are made to treat it; there are treatments.